Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Prothrombotic mutations, family history and the risk of thrombosis in postmenopausal women: implications for hormone replacement therapy.

Climacteric : the journal of the International Menopause Society - 1 Feb 2011

Botto N, Maffei S, Manfredi S, Colombo M G, Mazzone A M, Andreassi M G

Abstract excerpt

OBJECTIVE: Hormone replacement therapy (HRT) is acknowledged as the gold standard for the alleviation of climacteric vasomotor symptoms. Prothrombotic genetic variants have been suggested to increase thrombotic risk among HRT users. The aim of the study was to determine whether a positive family...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Diabetes Mellitus
Share to Dyslipidemias
Share to Factor V

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Hormone Replacement Therapy

Share to Myocardial Infarction

Share to Prothrombin

Share to Stroke

Share to Venous Thrombosis

Source

Identifiers

PMID: 21073356
DOI: 10.3109/13697137.2010.528814

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 2 Sept 2026. Prepared record publication-21073356-2026-09-02.2. Manifest publication-graph-cohort-2026-09-02.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 2 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Prothrombotic mutations, family history and the risk of thrombosis in postmenopausal women: implications for hormone replacement therapy.PMID 21073356Read ↗

Hormonal replacement therapy, prothrombotic mutations and the risk of venous thrombosis.Semantic proximity Read ↗

Factor V Leiden, prothrombin G20210A substitution and hormone therapy: indications for molecular screening.Semantic proximity Read ↗

Testing for inherited thrombophilia and consequences for antithrombotic prophylaxis in patients with venous thromboembolism and their relativesSemantic proximity Read ↗

Venous thrombosis and women's health : identification of risk factors and long terms effectsSemantic proximity Read ↗

Interaction of hemostatic genetics with hormone therapy: new insights to explain arterial thrombosis in postmenopausal women.Semantic proximity Read ↗

Prothrombin 20210A mutation: a mild risk factor for venous thromboembolism but not for arterial thrombotic disease and pregnancy-related complications in a family study.Semantic proximity Read ↗

Genetic risk factors for venous thrombosis in the elderly in a case-control study.Semantic proximity Read ↗

The impact of a male or female thrombotic family history on contraceptive counseling: a cohort study.Semantic proximity Read ↗

Estrogen therapy and thrombotic risk.Semantic proximity Read ↗

Factor V Leiden, hormone replacement therapy, and risk of venous thromboembolic events in women with coronary disease.Semantic proximity Read ↗

The effect of prothrombotic blood abnormalities on risk of deep vein thrombosis in users of hormone replacement therapy: a prospective case-control study.Semantic proximity Read ↗

Massive pulmonary embolism associated with Factor V Leiden, prothrombin, and methylenetetrahydrofolate reductase gene mutations in a young patient on oral contraceptive pills: a case report.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.